We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CellStream™ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

Watch Now

Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases

Blog

The failure of conventional antibiotics to treat numerous antibiotic-resistant infections necessitates the development of new agents – as a natural anti-microbial nitric oxide holds particular promise.

Read more

Research-grade Q-TOF LCMS-9030

Video

Shimadzu’s research-grade LCMS-9030 quadrupole time-of-flight (Q-TOF) mass spectrometer combines the engineering DNA from our proven triple quadrupole (LC-MS/MS) platform with powerful, new TOF architecture to transform high mass accuracy workflows.

Watch Now

The Agricultural Perspective on Water Contamination by Pharmaceuticals

Article

Despite centuries of research into drug development, investigation into the environmental impact of pharmaceuticals is a much younger field. If not treated effectively, there is the potential for pharmaceuticals in wastewater to affect the agricultural industry through the use of this contaminated water supply.

Read more

UHPLC- Robust Technology Built to Perform

Article

Chromatography is the backbone of analytical laboratories with high performance liquid chromatography (HPLC) representing the largest portion. Classical HPLC has been challenged - or complemented - in the last decade by ultrahigh performance liquid chromatography (UHPLC).

Read more
Automated Detection of Focal Epileptic Seizures

Automated Detection of Focal Epileptic Seizures

News

In a first-in-humans pilot study, researchers have identified a sentinel area of the brain that may give an early warning before clinical seizure manifestations appear.

Read more
 
No Cancer Risk for Telomerase Gene Therapy
News

Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.

Read more

Transcriptic to Oversee Robotic Cloud Lab For Eli Lilly
News

Transcriptic announced today that it has entered into an agreement with Eli Lilly and Company whereby Lilly will license the Transcriptic Common Lab Environment to enable on-demand drug discovery operations at its San Diego Biotechnology Center.

Read more

Autoscribe Informatics Expands Distribution Network
News

Autoscribe Informatics, a specialist provider of Laboratory Information Management Systems (LIMS), has expanded its worldwide distribution network. Corporación Científica Venezolana, CA has been appointed to cover South America, while V*I*Production sp z.o.o. will represent Autoscribe in Germany and Poland.

Read more

 
 
 
 
Is It Possible to Have a Google for EHR?

Is It Possible to Have a Google for EHR?

Article

Scanning through medical records at the speed of light is currently just a dream. In the future we can hope for a Google-like tool for EHR.

Read more
 
Ageing in Human Cells Successfully Reversed in the Lab
Article

"In our latest experiment, we have reversed the ageing of human cells, which could provide the basis for future anti-degeneration drugs."

Read more

A Micro-revolution with Giant Benefits
Article

With more and more applications of the microfluidics industry becoming apparent, giving scientists the tools they need has never been more important. This article highlights major industries that benefit from microfluidic technology, and provides insights into how demands for microfluidic components are changing.

Read more

The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020
Article

The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a compound annual growth rate (CAGR) of 49.1% during the forecast period 2015 to 2020, according to Allied Market Research’s report.

Read more